A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older

NCT00457249 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1564

Enrollment

INDUSTRY

Sponsor class

Conditions

Pertussis
Tetanus
Diphtheria

Interventions

BIOLOGICAL: ADACEL®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed
BIOLOGICAL: DECAVAC®: Tetanus and Diphtheria Toxoids Adsorbed

Sponsor

Sanofi